+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Emit® 2000 Cyclosporine Specific Assay, Extended Range: development of an application protocol for the V-Twin® analyzer



The Emit® 2000 Cyclosporine Specific Assay, Extended Range: development of an application protocol for the V-Twin® analyzer



Biotechnology and Applied Biochemistry 58(6): 476-482



We evaluated a new protocol for measurement of cyclosporine A (CsA) 2 H after dose (C2) on the V-Twin® analyzer. Imprecision, recovery, and linearity were determined using CsA-spiked blood pools. Accuracy was evaluated using specimens from renal, cardiac, and liver transplant patients, and results were compared with those from liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the Abbott TDx®/TDxFLx® assay. Cross-reactivity and interferences were assessed in the presence of 800 ng/mL CsA. Imprecision coefficients of variation were 3.3%-4.8% (within run) and 5.9%-8.7% (total). Recovery was within 10% of the expected values. Linearity was 350-2,000 ng/mL. Calibration was stable for ≥ 2 weeks. Method comparison showed regression statistics: V-Twin® = 1.01 × LC tandem MS + 36.1, r = 0.971; V-Twin® = 1.13 × Abbott - 92.4, r = 0.969. Metabolite cross-reactivity and interference (endogenous substances and drugs) were within ±10%. The C2 protocol on the V-Twin® analyzer provides acceptable assay performance and accurate determination of whole blood CsA drawn at 2 H after dose.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056181922

Download citation: RISBibTeXText

PMID: 22172110

DOI: 10.1002/bab.43


Related references

Homogenous enzyme immunoassay for cyclosporine in whole blood using the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus analyzer. Journal of Clinical Laboratory Analysis 15(6): 319-323, 2001

The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer. Clinical Biochemistry 37(11): 1022-1030, 2004

The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer. Annales de Biologie Clinique 66(6): 657-664, 2008

EMIT cyclosporine assay: development of an application protocol for Technicon AXON System. Clinical Biochemistry 27(5): 387-394, 1994

The EMIT cyclosporine assay - development of an application protocol for the technicon axon system. Clinical Biochemistry 27(3): 206-207, 1994

Evaluation of the Emit 2000 Tacrolimus Assay on the V-Twin Vitalab Analyzer. Clinical Chemistry 50(6, Suppl S, Part 2): A39, 2004

EMIT 2000 cyclosporine specific assay performance on COBAS MIRA Systems. Clinical Chemistry 42(6 Part 2): S206-S207, 1996

Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer. Clinical Biochemistry 39(10): 1041-1043, 2006

Performance characteristics of phencyclidine assay using Reply Analyzer and Emit d.a.u., Emit 700, and 1:1 (Emit d.a.u.-Emit 700) reagents. Journal of Analytical Toxicology 17(3): 188-189, 1993

Emit cyclosporine assay for whole blood samples on the cobas mira analyzer. Clinical Chemistry 36(6): 1034, 1990

The EMIT cyclosporine assay: Development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers. Clinical Biochemistry 30(2): 155-162, 1997

Development of application protocols for emit vancomycin assay on the syva autolab instrument system and for cobas mira analyzer. Clinical Chemistry 35(6): 1167, 1989

Evaluation of the Syva Emit 2000 digoxin assay on a Hitachi 717 analyzer. Clinical Biochemistry 29(4): 389-391, 1996

Evaluation of a new pretreatment reagent for use with the EMIT 2000 cyclosporine assay. Clinical Biochemistry 36(4): 313-316, 2003

Validation of the Syva Emit 2000 Cyclosporine assay on the Hitachi 917. Clinical Chemistry 48(6 Suppl.): A50, 2002